Status: Recruiting
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (TCR α/β TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with hematological malignancies. This is a safety/feasibility study of the investigational procedure/product.
Participants needed: 70
Trial details
Phase: Phase 2Age: Up to 60Biological sex: AllType: InterventionalSponsor: Masonic Cancer Center, University of MinnesotaUpdated: Apr 6, 2026Locations: 1
Eligibility criteria
Histological confirmation of hematological malignancies [+7]
Pregnant or breastfeeding. [+5]